Consumers fighting North Dakota pharmacy ownership law

The law means North Dakota consumers must travel elsewhere to buy the more than 300 drugs retailers
like Wal-Mart and Target offer for $4.

FDA speeds up review of Droxidopa

The drug is marketed in Japan to treat low blood pressure.

Pharmacy customers want self-service

The Wilson Rx Pharmacy Satisfaction Survey Report indicates pharmacy customers see convenience, price,
and overall pharmacy services as key to customer satisfaction.

Diabetes drug under scrutiny by FDA

The FDA plans to mandate a stronger label for a diabetes drug marketed by Amylin Pharmaceuticals and
Eli Lilly in the wake of deaths related to use of the drug.

Women’s health group seeks FDA help in clarifying labels for pregnant or breast-feeding women

Goal is to identify potential health risks for these groups of women.

Concordia receives first campaign gift toward pharmacy school

Shopko, a discount retailer, donated $1 million.

California pharmacists endorse halt of Medi-Cal cuts

California was directed by the Federal District Court in Los Angeles to stop the 10 percent cuts in
Medi-Cal reimbursement payments to healthcare providers.

Prescription drug ads: Where’s the beef?

This year’s prescription drug ads are not really impacting consumers.

Patients in low-income areas more sensitive to co-payment changes

The study investigated whether individuals in low-income areas are more strongly influenced by rising
prescription drug co-payments than individuals in higher income areas.

Medco, FDA forge research partnership

The collaboration will study genetic testing and the impact of genetics on the efficacy of
prescription drugs.